$BGXX
Bright Green Corp Stock $bgxx

$bgxx Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223018568 Filed on May 22, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.455M	$534.5K
YoY Change	359.29%	118.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$157.5K	$191.8K
YoY Change	-17.87%	3.47%
% of Gross Profit
Operating Expenses	$2.613M	$726.4K
YoY Change	259.69%	69.1%
Operating Profit	-$2.613M	-$726.3K
YoY Change	259.69%
Interest Expense	-$640.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$642.00
YoY Change
Pretax Income	-$2.613M	-$726.4K
YoY Change	259.78%	69.1%
Income Tax
% Of Pretax Income
Net Earnings	-$2.613M	-$726.4K
YoY Change	259.78%	69.1%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	-$4.610K
COMMON SHARES
Basic Shares Outstanding	173.4M shares	157.6M shares
Diluted Shares Outstanding	173.4M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$422.5K	$648.2K
YoY Change	-34.82%
Cash & Equivalents	$422.5K	$648.2K
Short-Term Investments
Other Short-Term Assets	$70.08K	$120.6K
YoY Change	-41.87%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$492.6K	$768.7K
YoY Change	-35.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.57M	$7.959M
YoY Change	133.37%
Goodwill
YoY Change
Intangibles	$1.000K
YoY Change
Long-Term Investments	$3.991M
YoY Change
Other Assets	$1.110M
YoY Change
Total Long-Term Assets	$23.68M	$7.960M
YoY Change	197.43%
TOTAL ASSETS
Total Short-Term Assets	$492.6K	$768.7K
Total Long-Term Assets	$23.68M	$7.960M
Total Assets	$24.17M	$8.729M
YoY Change	176.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.361M	$739.9K
YoY Change	759.65%
Accrued Expenses	$938.4K	$52.81K
YoY Change	1676.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.949M	$1.185M
YoY Change	655.25%
LONG-TERM LIABILITIES
Long-Term Debt	$3.460M	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$3.460M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.949M	$1.185M
Total Long-Term Liabilities	$3.460M	$0.00
Total Liabilities	$12.41M	$1.185M
YoY Change	947.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.69M
YoY Change
Common Stock	$48.45M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.76M	$7.544M
YoY Change
Total Liabilities & Shareholders Equity	$24.17M	$8.729M
YoY Change	176.88%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.613M	-$726.4K
YoY Change	259.78%	69.1%
Depreciation, Depletion And Amortization	$157.5K	$191.8K
YoY Change	-17.87%	3.47%
Cash From Operating Activities	$273.4K	$137.9K
YoY Change	98.28%
INVESTING ACTIVITIES
Capital Expenditures	$1.586M	-$822.3K
YoY Change	-292.83%
Acquisitions
YoY Change
Other Investing Activities	$47.94K
YoY Change
Cash From Investing Activities	-$1.538M	-$822.3K
YoY Change	87.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$880.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.272M	50.00K
YoY Change	2444.41%
NET CHANGE
Cash From Operating Activities	$273.4K	137.9K
Cash From Investing Activities	-$1.538M	-822.3K
Cash From Financing Activities	$1.272M	50.00K
Net Change In Cash	$7.928K	-634.4K
YoY Change	-101.25%
FREE CASH FLOW
Cash From Operating Activities	$273.4K	$137.9K
Capital Expenditures	$1.586M	-$822.3K
Free Cash Flow	-$1.312M	$960.2K
YoY Change	-236.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001886799
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses		usd
CY2023Q1	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate		usd
CY2022Q1	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate		usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2023Q1	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate		usd
CY2022Q1	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate		usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
CY2022Q1	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits		usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	BGXX	Transfer From Due To Related Party To Related Party Loc TransferFromDueToRelatedPartyToRelatedPartyLOC		usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41395
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BRIGHT GREEN CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-4600841
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1033 George Hanosh Boulevard
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Grants
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87020
CY2023Q1	dei	City Area Code CityAreaCode	(833)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	658-1799
CY2023Q1	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not Applicable
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	BGXX
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	174423810	shares
CY2023Q1	us-gaap	Cash Cash	422502	usd
CY2022Q4	us-gaap	Cash Cash	414574	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	70080	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77847	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	492582	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	492421	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1109643	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1157587	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3990960	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3990960	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18574396	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2023Q1	us-gaap	Assets Assets	24168581	usd
CY2022Q4	us-gaap	Assets Assets	22788293	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6360662	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5033831	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	938356	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	447325	usd
CY2023Q1	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2022Q4	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	392194	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8949018	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7523350	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3460092	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3686107	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3460092	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3686107	usd
CY2023Q1	us-gaap	Liabilities Liabilities	12409110	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11209457	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	174423810	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174423810	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	17441	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17329	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	48431116	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45637328	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36689086	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11759471	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24168581	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22788293	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2455082	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	534540	usd
CY2023Q1	us-gaap	Depreciation Depreciation	157541	usd
CY2022Q1	us-gaap	Depreciation Depreciation	191806	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2612623	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	726346	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2612623	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-726346	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-642	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	642	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2613265	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-726346	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2613265	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-726346	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-726346	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	173445814	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157555074	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2023Q1	BGXX	Stock Issued During Period Value Warrants Exercised For Cash StockIssuedDuringPeriodValueWarrantsExercisedForCash	210000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	823900	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11759471	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11759471	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-726346	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7544053	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7544053	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-726346	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-642	usd
CY2023Q1	us-gaap	Depreciation Depreciation	157541	usd
CY2022Q1	us-gaap	Depreciation Depreciation	191806	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	823900	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7767	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-47666	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1326189	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	589972	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	491031	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	34778	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-79586	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	273391	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	137876	usd
CY2023Q1	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits	-47944	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1585612	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	822265	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1537668	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-822265	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	17795	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	880000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	210000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1272205	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7928	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-634389	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	414574	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1282565	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	422502	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	648176	usd
CY2023Q1	BGXX	Transfer From Due To Related Party To Related Party Loc TransferFromDueToRelatedPartyToRelatedPartyLOC	392194	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	880000	usd
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-04-16
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-726346	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	273391	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	137876	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36689086	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2023Q1	BGXX	Working Capital WorkingCapital	-8456436	usd
CY2022Q4	BGXX	Working Capital WorkingCapital	-7030929	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	880000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	210000	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	200000	usd
CY2023Q1	BGXX	Transfer From Due To Related Party To Related Party Line Of Credit TransferFromDueToRelatedPartyToRelatedPartyLineOfCredit	392194	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	22005	shares
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	39.99	usd
CY2023Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	11500000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	11483	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	6191	usd
CY2023Q1	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zMtn85smneTb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zeIsdZgIv3I">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to valuation allowance for deferred tax assets, valuation of warrants and stock-based compensation, going concern assessment, and assignment of the useful lives of property, plant, and equipment. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	184718	usd
CY2022Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	187821	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	807047948	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	807047948	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	201761982	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3999999
CY2023Q1	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1650000	usd
CY2022Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1650000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.67	pure
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2023Q1	us-gaap	Land Land	260000	usd
CY2022Q4	us-gaap	Land Land	260000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	12321881	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10736269	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21554422	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19968810	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2980026	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2822485	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18574396	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	185703	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	106117	usd
CY2023Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2022Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	2219285	usd
CY2022	BGXX	Payments For Acquire Property Deposit PaymentsForAcquirePropertyDeposit	1109643	usd
CY2022	us-gaap	Payments For Deposits PaymentsForDeposits	1109642	usd
CY2022Q4	us-gaap	Construction Contract Cost Progress Payment Offset ConstructionContractCostProgressPaymentOffset	47944	usd
CY2023Q1	BGXX	Transfer From Due To Related Party To Related Party Loan Balance TransferFromDueToRelatedPartyToRelatedPartyLoanBalance	392194	usd
CY2023Q1	us-gaap	Transfer To Investments TransferToInvestments	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	22005	shares
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	39.99	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174423810	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	174423810	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2023Q1	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	200000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	210000	usd
CY2023Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	800000	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	55617	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	7650	usd
CY2023Q1	us-gaap	Share Price SharePrice	1.65
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.05
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	4489662	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3460092	usd
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_801_eus-gaap--LossContingencyDisclosures_z3IydyE64GMf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_829_zN7P3MijFIp7">Contingencies</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company is routinely defendants in, or parties to a number of pending and threatened legal actions including actions brought on behalf of various classes of claimants. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of such matters will be. Legal provisions are established when it becomes probable that the Company will incur an expense related to a legal action and the amount can be reliably estimated. Such provisions are recorded at the best estimate of the amount required to settle any obligation related to these legal actions as at the condensed balance sheet date, taking into account the risks and uncertainties surrounding the obligation. Management and internal and external experts are involved in estimating any amounts that may be required. The actual costs of resolving these claims may vary significantly from the amount of the legal provisions. The Company’s estimate involves significant judgement, given the varying stages of the proceedings, the fact that the Company’s liability, if any, has yet to be determined and the fact that the underlying matters will change from time to time. Other than as set forth below, the Company is not presently a party to any litigation. The Company is not able to make a reliable assessment of the potential losses as these matters are at an early stage, accordingly, no amounts have been accrued in the condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. John Fikany, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company filed a complaint for declaratory judgment against a consultant of the <span id="xdx_901_eus-gaap--LossContingencyActionsTakenByDefendant_c20230101__20230331__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zz1XvrHMtebb" title="Contingency, taken by defendant description">Bright Green Group of Companies, an entity unrelated to the Company, to determine if defendant is entitled to 5,000,000 shares of the Company’s common stock, based on a failure to fulfill agreed upon conditions precedent to earning such shares from the Company.</span> Defendant counterclaimed and filed a third-party claim against a director of the Company, and her spouse, for claims including wrongful termination and breach of contract. The Company denies defendants allegations and have set forth arguments refuting defendant’s counterclaims and third-party claims. The case is in the discovery phase. The Company is exploring potential dispositive motions against the counter and third-party claims.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><i>Bright Green Corporation v. Jerry Capussi, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company and defendant, a former consultant of Sunnyland Farms Inc., an entity unrelated to the Company, have each filed claims for declaratory judgment seeking to determine by court order whether defendant is entitled to <span id="xdx_900_eus-gaap--LossContingencyActionsTakenByDefendant_c20230101__20230331_zpcCOEvpGcq6" title="Contingency, taken by defendant description">(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grown Innovation, LLC (‘BGGI”). The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Loss Contingency Actions Taken By Defendant LossContingencyActionsTakenByDefendant	(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grown Innovation, LLC (‘BGGI”). The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.

Files In Submission

Name	View Source	Status
0001493152-23-018568-index-headers.html	Edgar Link	pending
0001493152-23-018568-index.html	Edgar Link	pending
0001493152-23-018568.txt	Edgar Link	pending
0001493152-23-018568-xbrl.zip	Edgar Link	pending
bgxx-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
bgxx-20230331_cal.xml	Edgar Link	unprocessable
bgxx-20230331_def.xml	Edgar Link	unprocessable
bgxx-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bgxx-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGXX
Bright Green Corp Stock $bgxx

2023 Q1 Form 10-Q Financial Statement

#000149315223018568 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX Bright Green Corp Stock $bgxx

2023 Q1 Form 10-Q Financial Statement

#000149315223018568 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX
Bright Green Corp Stock $bgxx